Literature DB >> 18633343

Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts.

Atsunori Nakao1, Gaetano Faleo, Hiroko Shimizu, Kiichi Nakahira, Junichi Kohmoto, Ryujiro Sugimoto, Augustine M K Choi, Kenneth R McCurry, Toru Takahashi, Noriko Murase.   

Abstract

Renal ischemia/reperfusion injury is a major complication of kidney transplantation. We tested if ex vivo delivery of carbon monoxide (CO) to the kidney would ameliorate the renal injury of cold storage that can complicate renal transplantation. Orthotopic syngeneic kidney transplantation was performed in Lewis rats following 24 h of cold preservation in University of Wisconsin solution equilibrated without or with CO (soluble CO levels about 40 microM). Ischemia/reperfusion injury in control grafts resulted in an early upregulation of inflammatory mediator mRNAs and progressive deterioration of graft function. In contrast, the grafts preserved with CO had significantly less oxidative injury and this was associated with improved recipient survival compared to the control group. Renal injury in the control group showed considerable degradation of cytochrome P450 heme proteins, active heme metabolism and increased detrimental intracellular free heme levels. Kidney grafts preserved in CO-equilibrated solution maintained their cytochrome P450 protein levels, had normal intracellular heme levels and had less lipid peroxidation. Our results show that CO-mediated suppression of injurious heme-derived redox reactions offers protection of kidney grafts from cold ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18633343     DOI: 10.1038/ki.2008.342

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  High-pressure carbon monoxide preserves rat kidney grafts from apoptosis and inflammation.

Authors:  Toyofumi Abe; Koji Yazawa; Masayuki Fujino; Ryoichi Imamura; Naoyuki Hatayama; Yoichi Kakuta; Koichi Tsutahara; Masayoshi Okumi; Naotsugu Ichimaru; Jun-Ya Kaimori; Yoshitaka Isaka; Kunihiro Seki; Shiro Takahara; Xiao-Kang Li; Norio Nonomura
Journal:  Lab Invest       Date:  2017-02-13       Impact factor: 5.662

Review 3.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

Review 4.  The therapeutic potential of carbon monoxide.

Authors:  Roberto Motterlini; Leo E Otterbein
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

5.  Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury.

Authors:  Junichi Kohmoto; Atsunori Nakao; Ryujiro Sugimoto; Yinna Wang; Jianghua Zhan; Hideo Ueda; Kenneth R McCurry
Journal:  J Thorac Cardiovasc Surg       Date:  2008-07-26       Impact factor: 5.209

6.  Preservation of the kidney by carbon monoxide: a black swan phenomenon.

Authors:  Karl A Nath
Journal:  Kidney Int       Date:  2008-10       Impact factor: 10.612

7.  Liver graft exposure to carbon monoxide during cold storage protects sinusoidal endothelial cells and ameliorates reperfusion injury in rats.

Authors:  Atsushi Ikeda; Shinya Ueki; Atsunori Nakao; Koji Tomiyama; Mark A Ross; Donna B Stolz; David A Geller; Noriko Murase
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

8.  The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression.

Authors:  H Song; C Bergstrasser; N Rafat; S Höger; M Schmidt; N Endres; M Goebeler; J L Hillebrands; R Brigelius-Flohé; A Banning; G Beck; R Loesel; B A Yard
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

9.  Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal.

Authors:  Sebastiaan Wesseling; Joost O Fledderus; Marianne C Verhaar; Jaap A Joles
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 10.  Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use.

Authors:  Inge Bauer; Benedikt H J Pannen
Journal:  Crit Care       Date:  2009-08-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.